Collaborating Implementation Site Director, Co-Director, Clinical Workgroup
Geraldine Dawson, Ph.D., Duke Collaborating Implementation Site (CIS) Director. Dr. Dawson is Professor of Psychiatry and Behavioral Sciences, Psychology, and Neuroscience and Director of the Duke Center for Autism and Brain Development at Duke University School of Medicine. Her research focuses on recognizing and understanding the neural bases of the earliest manifestations of autism and early interventions that can improve outcomes. Her laboratory pioneered the use of electrophysiological measures with very young children with autism to study the brain basis of impairments in social and language development. She is an expert in the use of EEG measures to assess brain function in individuals with ASD and has been the PI on a NIH-funded randomized clinical trial that utilized EEG as an endpoint. She co-led the team that developed and empirically-validated the first behavioral intervention for infants and toddlers with autism (Early Start Denver Model). Dr. Dawson is currently Co-PI on a program of clinical trials research evaluating the efficacy of umbilical cord blood therapy for reducing core symptoms of ASD using eye-tracking and EEG as surrogate endpoints. She regularly collaborates with other autism researchers from a wide range of disciplines, ranging from genetics to animal models to community dissemination research.
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.